Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

P3 Health Partners (PIIIW) Operating Expenses (2021 - 2025)

P3 Health Partners' Operating Expenses history spans 5 years, with the latest figure at $538.7 million for Q4 2025.

  • For Q4 2025, Operating Expenses rose 5.79% year-over-year to $538.7 million; the TTM value through Dec 2025 reached $1.7 billion, down 5.04%, while the annual FY2025 figure was $1.7 billion, 5.04% down from the prior year.
  • Operating Expenses reached $538.7 million in Q4 2025 per PIIIW's latest filing, up from $389.5 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $1.2 billion in Q2 2022 to a low of $164.3 million in Q1 2021.
  • Average Operating Expenses over 5 years is $415.1 million, with a median of $389.7 million recorded in 2025.
  • Peak YoY movement for Operating Expenses: surged 592.81% in 2022, then crashed 70.37% in 2023.
  • A 5-year view of Operating Expenses shows it stood at $188.5 million in 2021, then soared by 321.61% to $794.8 million in 2022, then tumbled by 48.27% to $411.1 million in 2023, then increased by 23.85% to $509.2 million in 2024, then increased by 5.79% to $538.7 million in 2025.
  • Per Business Quant, the three most recent readings for PIIIW's Operating Expenses are $538.7 million (Q4 2025), $389.5 million (Q3 2025), and $389.9 million (Q2 2025).